Genomics, Artificial Intelligence, Biology, Pharmaceutical, Cancer.
new targets for therapeutic intervention. Histone Modifiers: The Epigenetic Architects in Cancer Histone modifiers such as EZH2, part of the PRC2 complex, play a significant role in the epigenetic reprogramming observed in cancer. ChIP-seq for histone marks has revealed how these enzymes alter the